SEK 3.06
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 100.87 Million SEK | 5.27% |
2022 | 95.82 Million SEK | 6.66% |
2021 | 89.83 Million SEK | 48.44% |
2020 | 60.52 Million SEK | 7.75% |
2019 | 56.16 Million SEK | 14.54% |
2018 | 49.03 Million SEK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q3 | 16.09 Million SEK | -19.36% |
2024 Q2 | 19.95 Million SEK | 0.5% |
2024 Q1 | 19.85 Million SEK | -55.23% |
2023 Q3 | 17.73 Million SEK | -11.03% |
2023 FY | 100.87 Million SEK | 5.27% |
2023 Q4 | 44.35 Million SEK | 150.04% |
2023 Q2 | 19.93 Million SEK | 5.79% |
2023 Q1 | 18.84 Million SEK | -26.75% |
2022 Q3 | 19.95 Million SEK | -19.62% |
2022 Q2 | 24.82 Million SEK | -1.9% |
2022 Q1 | 25.3 Million SEK | -10.66% |
2022 FY | 95.82 Million SEK | 6.66% |
2022 Q4 | 25.72 Million SEK | 28.92% |
2021 FY | 89.83 Million SEK | 48.44% |
2021 Q4 | 28.32 Million SEK | 37.54% |
2021 Q3 | 20.59 Million SEK | 1.64% |
2021 Q2 | 20.26 Million SEK | 2.21% |
2021 Q1 | 19.82 Million SEK | 50.09% |
2020 FY | 60.52 Million SEK | 7.75% |
2020 Q4 | 13.2 Million SEK | 0.0% |
2020 Q3 | 13.2 Million SEK | 12.14% |
2020 Q2 | 11.77 Million SEK | 0.0% |
2020 Q1 | 11.77 Million SEK | 0.0% |
2019 FY | 56.16 Million SEK | 14.54% |
2018 FY | 49.03 Million SEK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Aino Health AB (publ) | 13.31 Million SEK | -657.802% |
Bonzun AB (publ) | 5.00 SEK | -2017419900.0% |
Kontigo Care AB (publ) | 43.23 Million SEK | -133.33% |
RaySearch Laboratories AB (publ) | 800.7 Million SEK | 87.402% |
Surgical Science Sweden AB (publ) | 367.6 Million SEK | 72.56% |